Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Bull of the Day: CNO Financial

by Zacks Equity Research

January 18, 2013 | Comments : 0 Recommended this article: (0)
CNO

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We are upgrading our recommendation on CNO Financial (CNO) to Outperform based on the hike in its buyback program and prospects of significant capital deployment in 2013. The latest recapitalization plan has also improved the capital structure and debt maturity profile. It is also expected to augment the bottom line and ROE.

However, high financial leverage and constantly deteriorating Bankers Life segment results are the downsides. The company's third-quarter earnings surpassed the Zacks Consensus Estimate and the year-ago numbers on the back of favorable trends in annuity spreads, improved top line and benefit ratios and better investment results.

Improved credit ratings, strong investment portfolio and declining expenses are the other positives. Although underwriting and pricing challenges remain primary concerns, increasing new business volume and cost containment measures are expected to support the bottom line in the long run.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.